Bacterial infections are often polymicrobial. and cause chronic co-infections, which are more problematic than mono-species infections. Understanding the mechanisms of their interactions is crucial for treating co-infections. Staphyloxanthin (STX), a yellow pigment synthesized by the operon, promotes resistance to oxidative stress and neutrophil-mediated killing. We found that STX production by , either as surface-grown macrocolonies or planktonic cultures, was elevated when exposed to the exoproduct, 2-heptyl-4-hydroxyquinoline N-oxide (HQNO). This was observed with both mucoid and non-mucoid strains. The induction phenotype was found in a majority of and clinical isolates examined. When subjected to hydrogen peroxide or human neutrophils, survival was significantly higher when mixed with wild-type (WT) , compared to alone or with an mutant deficient in STX production. In a murine wound model, co-infection with WT , but not the STX-deficient mutant, enhanced burden and disease compared to mono-infection. In conclusion, we identified a role for HQNO mediating polymicrobial interactions with by inducing STX production, which consequently promotes resistance to the innate immune effectors HO and neutrophils. These results further our understanding of how different bacterial species cooperatively cause co-infections.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10786307 | PMC |
http://dx.doi.org/10.1073/pnas.2312334121 | DOI Listing |
Epidemiol Infect
January 2025
Gastrointestinal Infections and Food Safety (One Health) Division, Clinical and Public Health Group, UK Health Security Agency, London, UK.
In July 2022, a genetically linked and geographically dispersed cluster of 12 cases of Shiga toxin-producing (STEC) O103:H2 was detected by the UK Health Security Agency using whole genome sequencing. Review of food history questionnaires identified cheese (particularly an unpasteurized brie-style cheese) and mixed salad leaves as potential vehicles. A case-control study was conducted to investigate exposure to these products.
View Article and Find Full Text PDFJ Infect Dis
January 2025
Division of Environmental Health Sciences, School of Public Health, University of Minnesota, St. Paul, MN 55108, USA.
Shiga toxin-producing Escherichia coli (STEC) infections pose a significant public health challenge, characterized by severe complications including hemolytic uremic syndrome (HUS) due to Shiga toxin (Stx) production. Current therapeutic approaches encounter a critical limitation, as conventional antibiotic treatment is contraindicated due to its propensity to trigger bacterial SOS response and subsequently enhance Stx production, which increases the likelihood of developing HUS in antibiotic-treated patients. The lack of effective, safe therapeutic options has created an urgent need for alternative treatment strategies for STEC infections.
View Article and Find Full Text PDFFoodborne Pathog Dis
December 2024
Department of Pediatric Nephrology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Shiga toxin-producing (STEC) refers to a group of bacteria that can cause infections, which are common worldwide and pose a serious public health problem, as they can lead to conditions such as hemorrhagic colitis and hemolytic uremic syndrome (HUS). HUS is a disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. Determination of serogroups and toxin profiles of STEC is important for estimating their disease-causing potential and predicting epidemiological changes.
View Article and Find Full Text PDFJ Great Lakes Res
June 2024
F.T Stone Laboratory, The Ohio State University, 878 Bayview Ave. Put-in-Bay, OH 43456, USA.
Cyanobacterial blooms in the western basin of Lake Erie have been well studied with a focus on planktonic and the cyanotoxin microcystin, but recent research has shown that blooms are not entirely . Previous studies have documented other taxa in blooms capable of producing other cyanotoxins. Furthermore, benthic cyanobacteria have historically been overlooked in Lake Erie.
View Article and Find Full Text PDFJ Patient Rep Outcomes
December 2024
NIHR King's Clinical Research Facility and Headache Group, King's College, London, UK.
Background: Eptinezumab's impact on self-reported work productivity in adults with migraine and 2‒4 prior preventive migraine treatment failures is not fully understood.
Methodology: Electronic diaries captured monthly migraine days (MMDs) reported by patients enrolled in the randomized, double-blind, placebo-controlled DELIVER trial (NCT04418765). The migraine-specific Work Productivity and Activity Impairment questionnaire, administered at baseline and each monthly visit, was a secondary outcome of DELIVER and used to model changes from baseline in self-reported monthly hours of absenteeism (decreased work attendance) and presenteeism (reduced work efficiency while at work with a migraine) in Canada, as the base case.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!